| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Apr, 2026 | Apr, 2026 |
| Sales | 0 | 0 | 10 | 0 | 0 |
| Sales Growth | unch | -100.00% | unch | unch | unch |
| Net Income | -896 | -857 | -474 | 0 | 0 |
| Net Income Growth | -4.50% | -80.93% | unch | unch | unch |
1600 0.000 0.000 (EYE.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Rise Nano Optics Ltd is engaged in developing and commercializing inventive eyewear that reduces the risk of diabetes-related eye diseases and has developed the Eyegard, an eyeglass filter that uses developed nanotechnology to block harmful wavelengths in a wide variety of applications.
Fiscal Year End Date: 12/31